Literature DB >> 2103333

Optimal collection of blood samples for the measurement of tumor necrosis factor alpha.

A R Exley1, J Cohen.   

Abstract

We have examined how delayed separation of plasma from cells affects the recovery of recombinant human tumor necrosis factor alpha (rhTNF alpha) from whole blood. Storage of heparinized whole blood samples at room temperature for 1 hr results in a significant (p = 0.036) fall in recovery of plasma TNF alpha from 788 +/- 119 pg/mL to 472 +/- 77 pg/mL, measured by specific enzyme-linked immunosorbent assay (ELISA). Storage of whole blood samples at 4 degrees C for 1 hr reduces but does not prevent the fall in recovery of plasma TNF alpha: 725 +/- 82 pg/mL at time 0, 472 +/- 81 pg/mL after 1 hr, p = 0.038. Recovery of bioactive TNF alpha (cytotoxocity for L929 cells) after 1 hr at room temperature is also significantly reduced from 576 +/- 139 pg/mL to 450 +/- 154 pg/mL, p = 0.036. Studies with 125I-rhTNF alpha confirmed the fall in plasma activity and revealed a rapid commensurate increase in 125I-rhTNF alpha activity in the cell fractions. We recommend that clinical samples for the measurement of cytokines should be kept at 4 degrees C and separated rapidly (within half an hour) before storing the plasma at -70 degrees C.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2103333     DOI: 10.1016/1043-4666(90)90065-2

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  13 in total

1.  Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis.

Authors:  A R Exley; T Leese; M P Holliday; R A Swann; J Cohen
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

2.  Effect of storage temperatures on the stability of cytokines in cervical mucous.

Authors:  Gitika Panicker; Kristi S Meadows; Daisy R Lee; Rosane Nisenbaum; Elizabeth R Unger
Journal:  Cytokine       Date:  2007-04-20       Impact factor: 3.861

3.  Obstructive sleep apnea, excessive daytime sleepiness, and morning plasma TNF-α levels in Greek children.

Authors:  Emmanouel I Alexopoulos; Vasiliki Theologi; Georgia Malakasioti; Panagiotis Maragozidis; Irene Tsilioni; George Chrousos; Konstantinos Gourgoulianis; Athanasios G Kaditis
Journal:  Sleep       Date:  2013-11-01       Impact factor: 5.849

4.  Platelet-rich plasma or blood-derived products to improve endometrial receptivity?

Authors:  Adriana Bos-Mikich; Marcelo O Ferreira; Ricardo de Oliveira; Nilo Frantz
Journal:  J Assist Reprod Genet       Date:  2019-01-04       Impact factor: 3.412

5.  Effects of blood sample age at time of separation on measured cytokine concentrations in human plasma.

Authors:  Rachael P Jackman; Garth H Utter; John W Heitman; Dale F Hirschkorn; Jacqueline P Law; Nelly Gefter; Michael P Busch; Philip J Norris
Journal:  Clin Vaccine Immunol       Date:  2010-12-15

6.  Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures.

Authors:  N Aziz; P Nishanian; J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

7.  Variables that affect assays for plasma cytokines and soluble activation markers.

Authors:  N Aziz; P Nishanian; R Mitsuyasu; R Detels; J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

8.  Association between serum-soluble CD8 levels and parameters of immune activation in patients with human immunodeficiency virus infection.

Authors:  G P Tilz; R Zangerle; G Weiss; P Fritsch; H Wachter; D Fuchs
Journal:  Clin Investig       Date:  1992-08

9.  Serum levels of the soluble receptor for tumor necrosis factor in patients with renal disease.

Authors:  G Halwachs; A Tiran; E C Reisinger; R Zach; K Sabin; B Fölsch; H Lanzer; H Holzer; M Wilders-Truschnig
Journal:  Clin Investig       Date:  1994-06

Review 10.  Molecular signatures of obstructive sleep apnea in adults: a review and perspective.

Authors:  Erna S Arnardottir; Miroslaw Mackiewicz; Thorarinn Gislason; Karen L Teff; Allan I Pack
Journal:  Sleep       Date:  2009-04       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.